v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 13,004 $ 25,378
General and administrative 5,938 5,943
Total operating expenses 18,942 31,321
Loss from operations (18,942) (31,321)
Other income (expense)    
Interest income 1,250 1,122
Other (expense) income, net (56) (3)
Total other income, net 1,194 1,119
Net loss before income tax (17,748) (30,202)
Income tax expense (15) 0
Net loss $ (17,763) $ (30,202)
Net loss per share, basic $ (0.26) $ (0.92)
Net loss per share, diluted $ (0.26) $ (0.92)
Weighted-average common stock outstanding, basic 69,091,100 32,674,720
Weighted-average common stock outstanding, diluted 69,091,100 32,674,720
Other comprehensive (loss) income:    
Cumulative translation adjustment arising during the period $ 0 $ (1)
Unrealized loss on marketable securities (70) (44)
Comprehensive loss $ (17,833) $ (30,247)